What is Citius Oncology, Inc.'s total cost of revenue?

Citius Oncology, Inc. (CTOR) reported total cost of revenue of $328.88K in Q1 2026.

What does total cost of revenue mean?

The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.

Citius Oncology, Inc. CTOR Total Cost of Revenue

Total Cost of Revenue at other companies

Merck & Co.MRK

$4.2B+22.7%

Delcath SystemsDCTH

$3.74M+31.3%

Iovance Biotherapeutics, Inc.IOVA

$42.5M-0.5%

ImmunityBio, Inc.IBRX

$238K+310%

Gilead SciencesGILD

$1.45B-6.2%

United TherapeuticsUTHR

$133.4M+44.2%

Other financials

Income statement

See full

Revenue$1.7M—

Gross profit$1.3M—

Operating income-$28.6M-283%

Net income-$26.6M-244%

EPS (diluted)-$0.27-145%

Balance sheet

See full

Cash & equivalents$2.6M+2,350,466%

Total equity$35.3M-1.0%

Total assets$100.7M+10.1%

Cash flow

See full

Operating cash flow-$3.8M-179%

Valuation

See full

Market cap$60.45M-74.7%

Returns & leverage

See full

Return on equity-119.9%+46.7pp

Current ratio0.5×+0.1×

Where this comes from

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CostOfRevenue.

The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Citius Oncology, Inc.'s total cost of revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Citius Oncology, Inc.'s total cost of revenue?: Citius Oncology, Inc. (CTOR) reported total cost of revenue of $328.88K in Q1 2026.
What does total cost of revenue mean?: The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.